Skip to main content

Table 1 Demographics Clinical Characteristics at baseline

From: One-year follow-up of the effectiveness and mediators of cognitive behavioural therapy among adults with attention-deficit/hyperactivity disorder: secondary outcomes of a randomised controlled trial

 

CBT + M (n = 49)

M (n = 49)

χ2/t value

p value

Male(%)

27 (55.1)

31 (63.3)

0.676

0.411

age [mean (SD)]

26.8 (5.7)

24.8 (5.6)

1.816

0.072

FIQ [mean (SD)]

122.8 (9.1)

119.5 (9.8)

1.704

0.092

ADHD subtype (%)

    
 

Predominantly inattentive

31 (63.3)

28 (57.1)

0.383

0.536

 

Combined

18 (36.7)

21 (42.9)

  

Year of education [mean (SD)]

16.4 (2.4)

15.7 (2.5)

1.454

0.149

Current Axis I Disorder (%)

21 (42.9)

23 (46.9)

0.165

0.685

≥1 Current Axis I Disorder (%)

7 (14.3)

8 (16.3)

0.079

0.779

Affective Disorder (%)

11 (22.5)

14 (28.6)

0.483

0.487

 

Bipolar Disorder

4 (8.16)

4 (8.16)

0.000

1.000

 

Major Depressive Disorder (%)

6 (12.24)

9 (18.37)

0.708

0.400

 

Dysthymia (%)

1 (2.04)

2 (4.08)

0.344

1.000

Anxiety Disorder (%)

13 (26.5)

10 (20.4)

0.511

0.475

Comorbid Axis I disorders in remission (%)

4 (8.2)

7 (14.3)

0.922

0.337

 

Affective Disorder (%)

4 (8.2)

6 (12.2)

0.445

0.505

 

Anxiety Disorder (%)

0 (0.0)

1 (6.7)

1.010

1.000

Current comorbid Axis II disorders (%)

27 (55.1)

26 (53.1)

0.041

0.839

≥1 Axis II Disorder (%)

9 (18.4)

11 (22.5)

0.251

0.616

 

Cluster A (%)

8 (16.3)

8 (16.3)

0.000

1.000

 

Cluster B (%)

4 (8.2)

6 (12.2)

0.445

0.505

 

Cluster C (%)

22 (44.9)

19 (38.8)

0.633

0.426

 

Other (%)

9 (18.8)

15 (30.6)

1.986

0.159

Medication

    
 

Methylphenidate (Concerta®)

47 (95.9)

46 (93.9)

1.069

1.000

 

Atomoxetine (Strattera®)

2 (4.1)

2 (4.1)

  
 

Methylphenidate+Atomoxetine

0 (0.0)

1 (2.0)

  
  1. FIQ full-scaled intelligence quotient; Axis II Cluster A: Paranoid Personality Disorder, Schizoid Personality Disorder, Schizotypal Personality Disorder; Axis II Cluster B: Antisocial personality disorder, Borderline personality disorder, Schizophrenic personality disorder, Narcissistic personality disorder; Axis II Cluster C: Avoidance personality disorder, Dependent personality disorder, Obsessive-Compulsive Personality Disorder; Axis II Other: Personality Change Due to Another Medical Condition, Other Specified Personality Disorder, Unspecified Personality Disorder. CBT + M: the CBT combined with medication group; M: the medication-only group